Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA To potentially include adolescents and antibody persistence up to two years Saint Herblain (France), November 26, 2024 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the U.S. Food and Drug Administration (FDA) to potentially extend the use of its chikungunya vaccine IXCHIQ®, which is currently approved in adults, to adolescents aged 12 to 17 years. The application also includes adding the two-year anti...
In today's Morning Views publication we comment on developments of the following high yield issuers: Loxam, Modulaire, Progroup, Forgital, Voyage Care, Tele Columbus, Industria Macchine Automatiche, Vallourec, Assemblin, PeopleCert, Novafives, Eolo, Altice France (SFR), Altice International, Multiversity, Grunenthal, Ontex, Benteler International, Rolls-Royce, Axactor, Grupo Antolin
Vallourec to Sell Logistics Group (Indonesia) for €20 Million VALLOUREC TO SELL LOGISTICS GROUP (INDONESIA) FOR €20 MILLION Meudon (France), November 25, 2024 – Vallourec, a world leader in premium seamless tubular solutions, announces today that it has entered into an agreement to sell its c. 99% participation in PT CPPI and PT SCN (“Logistics Group”) to CKB Logistics, a subsidiary of ABM Investama Tbk, for approximately €20 million, of which €2.9 million will be paid via an earn-out. Based in Batam, Indonesia, Logistics Group provides integrated port and logistics services to a gro...
Aalberts: highlights ING Benelux Conference Brussels 2024, Ackermans & Van Haaren: Highlights ING Benelux Conference Brussels,Ackermans & Van Haaren: Strong operational performance of underlying companies and guidance fine-tuned upwards, AMG: Highlights ING Benelux Conference Brussels, Aperam: Highlights ING Benelux Conference Brussels, Arcadis: Highlights ING Benelux conference, Azelis: Highlights ING Benelux Conference Brussels, Bekaert: Guidance cut and €200m buyback as sweetener, CFE: No new...
>Outperform, target price € 54 - Following the earnings release and the conference call, we have very marginally adjusted our 2024-2026e EBITDA forecast. International momentum via AMS business is showing signs of an inflection (destocking, pressure on prices, etc.). The decline in the EPS estimates at the group level is due solely to adjustments for this division.The aim to ramp up on new businesses should be clarified in early 2025 and could materialise through...
>Opinion Surperformance et OC abaissé à 54 € - Post publication et conférence call, nous avons très marginalement ajusté notre séquence d’EBITDA 2024/2026e. La dynamique à l’International montre des signes d’inflexion (déstockage, pression sur les prix…). La baisse des BPA au niveau du groupe provient uniquement d’ajustements au niveau de cette division.La volonté d’accélération sur de nouveaux métiers devrait être clarifiée début 2025 et pourrait passer par des ...
EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): 9 Month figures/Quarter Results SBO with solid results and higher cash flow in a challenging market environment 21.11.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. SBO with solid results and higher cash flow in a challenging market environment 1-9/2024: Sales of MEUR 425.6 sustained by 8.7% growth in the OE division, EBIT at MEUR 51.8, free cash flow improved to MEUR 42.5 Q3 2024: OE division with significant sales and EBIT improvement, AMS division sales a...
EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Schlagwort(e): 9-Monatszahlen/Quartalsergebnis SBO mit soliden Ergebnissen und höherem Cashflow in herausforderndem Marktumfeld 21.11.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SBO mit soliden Ergebnissen und höherem Cashflow in herausforderndem Marktumfeld 1-9/2024: Umsatz von MEUR 425,6 durch 8,7% Wachstum in der OE-Division unterstützt, EBIT bei MEUR 51,8, Freier Cashflow auf MEUR 42,5 verbessert Q3 2024: OE-Division mit deutlicher Umsatz- und EBIT-Verbesse...
>A convincing road show regarding the growth and resilience drivers - We organised two days of road shows in London and Amsterdam with Aperam's CFO, Sudhakar Sivaji, following the release of solid Q3 results and the announcement of the planned acquisition of Universal Stainless, a US producer of specialty stainless mainly for aerospace. Whilst Aperam remains largely perceived by investors as dependent on the European macro economy, our discussions highlighted the meri...
>Roadshow convaincant sur les moteurs de croissance et de résilience - Nous avons organisé deux journées de roadshows avec le CFO d’Aperam Sudhakar Sivaji à Londres et Amsterdam dans la foulée de résultats T3 solides et du projet d’acquisition d’Universal Stainless, un producteur US d’aciers inoxydables de spécialité principalement pour l’aéronautique. Alors qu’Aperam reste encore largement perçu par les investisseurs comme dépendant de la macro européenne, les discus...
Vallourec Third Quarter 2024 Results Meudon (France), November 15th, 2024 Vallourec, a world leader in premium tubular solutions, announces today its results for the third quarter 2024. The Board of Directors of Vallourec SA, meeting on November 14th 2024, approved the Group's third quarter 2024 Consolidated Financial Statements. Third Quarter 2024 Results Q3 EBITDA of €168m, EBITDA margin remained strong at 19%Very strong total cash generation, with €130 million in Q3Net debt now €240 million, marking eighth consecutive quarter of deleveragingGroup full year EBITDA guidance of €800 – €...
Vallourec : Résultats du Troisième Trimestre 2024 Meudon (France), le 15 novembre 2024 Vallourec, un leader mondial de solutions tubulaires premium, annonce aujourd’hui ses résultats du troisième trimestre 2024. Le Conseil d’Administration de Vallourec SA, réuni le 14 novembre 2024, a arrêté les comptes consolidés du Groupe pour le troisième trimestre 2024. Résultats du Troisième Trimestre 2024 RBE de 168 millions d’euros ; solide marge de RBE de 19 % Très forte génération de trésorerie globale de 130 millions d’eurosDette nette ramenée à 240 millions d’euros : huitième trimestre conséc...
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 Saint Herblain (France) and Schlieren (Zurich), November 13, 2024 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and , a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the first participant has been vaccinated in a Phase 2b controlled human infection model (CHIM) study of Shigella4V2 (S4V2), the world’s most clinically advanced tetravalent bioconjugate shigellosis vacc...
Aperam S.A. / Mot-clé(s) : Autres Designated Person Notification 13-Nov-2024 / 10:51 CET/CEST Designated Person Notification Luxembourg, 13 November 2024 (10:30 CET) - With reference to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulations), Aperam announces that one notification of share transactions by a Designated Person (i.e. Directors or Executive Officers) is available in the Luxembourg Stock Exchange’s electronic database OAM on and on Aperam’s web site under Investors > Ne...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.